Clinical Trial

Showing results 61 - 70 of 71

Sorted by most recent

TitleAuthorDate

Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)

Lukas Dostalek, Ingo Runnebaum, Francesco Raspagliesi, Ignace Vergote, Ladislav Dusek, Jiri Jarkovsky, David Cibula

20 November 2019

A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

Juan Francisco Grau, Lorena Farinas-Madrid, Ana Oaknin

23 October 2019

Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY)

Giovanni Scambia, Camilla Nero, Stefano Uccella, Enrico Vizza, Fabio Ghezzi, Francesco Cosentino, Vito Chiantera, Anna Fagotti

9 October 2019

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

Alexander Reuss, Andreas du Bois, Philipp Harter, Christina Fotopoulou, Jalid Sehouli, Giovanni Aletti, Frederic Guyon, Stefano Greggi, Berit Jul Mosgaard, Alexander Reinthaller, Felix Hilpert, Carmen Schade-Brittinger, Dennis S Chi, Sven Mahner

15 August 2019

GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study

Debora Verri, Tina Pasciuto, Elisabeth Epstein, Robert Fruscio, Floriana Mascilini, Francesca Moro, Giovanni Scambia, Lil Valentin, Antonia Carla Testa

26 June 2019

Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial

Henrik Falconer, Kolbrun Palsdottir, Karin Stalberg, Pernilla Dahm-Kähler, Ulrika Ottander, Evelyn Serreyn Lundin, Lena Wijk, Rainer Kimmig, Pernille Tine Jensen, Ane Gerda Zahl Eriksson, Johanna Mäenpää, Jan Persson, Sahar Salehi

14 June 2019

FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study

Marie Plante, Nienke van Trommel, Stephanie Lheureux, Amit M Oza, Lisa Wang, Karolina Sikorska, Sarah Elizabeth Ferguson, Kathy Han, Frederic Amant

17 May 2019

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

Fabrice R Lecuru, Mary McCormack, Peter Hillemanns, Amelie Anota, Mario Leitao, Patrice Mathevet, Ronald Zweemer, Keiichi Fujiwara, Vanna Zanagnolo, Ane Gerda Zahl Eriksson, Emma Hudson, Gwenael Ferron, Marie Plante

20 March 2019

International radical trachelectomy assessment: IRTA study

Gloria Salvo, Pedro T Ramirez, Mario Leitao, David Cibula, Christina Fotopoulou, Ali Kucukmetin, Gabriel Rendon, Myriam Perrotta, Reitan Ribeiro, Marcelo Vieira, Glauco Baiocchi, Henrik Falconer, Jan Persson, Xiaohua Wu, Mihai Emil CăpilnaSee the full list of authors

13 February 2019

Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer

Kathleen N Moore, Sandro Pignata, on behalf of the IMagyn050 Steering Committee

10 January 2019

Prev 1 2 3 4 5 678 Next